Skip to main content
Log in

Intravenous pamidronate in treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Braun J, Brandt J, Listing J, et al.: Treatment of active ankylosing spondylitis with infliximab:a randomized controlled multicenter trial. Lancet 2002, 359:1187–1193.

    Article  PubMed  CAS  Google Scholar 

  2. Van den Bosch F, Kruithof E, Baeten D, et al.: Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor-alpha (infliximab) versus placebo in spondyloarthropathy. Arthritis Rheum 2002, 46:755–765.

    Article  CAS  Google Scholar 

  3. Kahn AK: Update on spondyloarthropathies. Ann Int Med 2002, 136:896–907.

    Google Scholar 

  4. Ralston SH, Hacking L, Willocks L, et al.: Clinical, biochemical and radiographic effects of aminohydroxypylidene bisphosphonate treatment in rheumatoid arthritis. Ann Rheum Dis 1989, 48:396–399.

    Article  PubMed  CAS  Google Scholar 

  5. Calin A, Nakache JP, Gueguen A, et al.: Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument? Rheumatology 1999, 38:878–882.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritchlin, C.T. Intravenous pamidronate in treatment of nonsteroidal anti-inflammatory drug-refractory ankylosing spondylitis. Curr Rheumatol Rep 4, 498–499 (2002). https://doi.org/10.1007/s11926-002-0056-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-002-0056-3

Keywords

Navigation